Ebert Ellen C, Groh Veronika
UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Immunology. 2008 May;124(1):33-41. doi: 10.1111/j.1365-2567.2007.02656.x. Epub 2008 Feb 13.
Human intestinal intraepithelial lymphocytes (IELs), which are T-cell receptor alphabeta+ CD8+ T cells located between epithelial cells (ECs), are likely to participate in the innate immune response against colon cancer. IELs demonstrate spontaneous cytotoxic (SC) activity specifically directed against EC tumours but not against other solid tumour types. The aim of this study was to dissect out the mechanism of SC activity, focusing on the interaction of NKG2D on IELs with its ligands [major histocompatibility complex (MHC) class I chain-related protein (MIC) and UL16 binding protein (ULBP)] found mainly on EC tumours. A novel series of events occurred. The NKG2D-MIC/ULBP interaction induced Fas ligand (FasL) production and FasL-mediated SC activity against HT-29 cells and MIC-transfectants. Tumour necrosis factor-alpha and interferon-gamma, produced independently of this interaction, promoted SC activity. The immune synapse was strengthened by the interaction of CD103 on IELs with E-cadherin on HT-29 cells. Neither T-cell receptor nor MHC class I was involved. While the HT-29 cells were destroyed by soluble FasL, tumour necrosis factor-alpha and interferon-gamma, the IELs were resistant to the effects of these mediators and to FasL expressed by the HT-29 cells. This unidirectional FasL-mediated cytotoxicity of IELs against HT-29 cells, triggered through NKG2D, is unique and is likely to be a property of those CD8+ tumour-infiltrating lymphocytes that phenotypically resemble IELs.
人肠道上皮内淋巴细胞(IELs)是位于上皮细胞(ECs)之间的T细胞受体αβ + CD8 + T细胞,可能参与针对结肠癌的先天免疫反应。IELs表现出特异性针对EC肿瘤而非其他实体瘤类型的自发细胞毒性(SC)活性。本研究的目的是剖析SC活性的机制,重点关注IELs上的NKG2D与其主要在EC肿瘤上发现的配体[主要组织相容性复合体(MHC)I类链相关蛋白(MIC)和UL16结合蛋白(ULBP)]之间的相互作用。一系列新的事件发生了。NKG2D-MIC/ULBP相互作用诱导Fas配体(FasL)产生以及FasL介导的针对HT-29细胞和MIC转染细胞的SC活性。独立于这种相互作用产生的肿瘤坏死因子-α和干扰素-γ促进了SC活性。IELs上的CD103与HT-29细胞上的E-钙黏蛋白之间的相互作用增强了免疫突触。T细胞受体和I类MHC均未参与。虽然HT-29细胞被可溶性FasL、肿瘤坏死因子-α和干扰素-γ破坏,但IELs对这些介质的作用以及HT-29细胞表达的FasL具有抗性。这种通过NKG2D触发的IELs对HT-29细胞的单向FasL介导的细胞毒性是独特的,并且可能是那些表型类似于IELs的CD8 +肿瘤浸润淋巴细胞的特性。